112 related articles for article (PubMed ID: 12433047)
1. [99mTc]Technetium labelled PnAo-azomycin glucuronides: a novel class of imaging markers of tissue hypoxia.
Kumar P; Wiebe LI; Mannan RH; Zhang Z; Xia H; McEwan AJ
Appl Radiat Isot; 2002 Nov; 57(5):719-28. PubMed ID: 12433047
[TBL] [Abstract][Full Text] [Related]
2. A novel amine-dioxime chelator for technetium-99m: synthesis and evaluation of 2-nitroimidazole-containing analogues as markers for hypoxic cells.
Su ZF; Ballinger JR; Rauth AM; Abrams DN; Billinghurst MW
Bioconjug Chem; 2000; 11(5):652-63. PubMed ID: 10995208
[TBL] [Abstract][Full Text] [Related]
3. Preparation and bioevaluation of a novel
Li S; Chu T
Bioorg Med Chem Lett; 2024 Jul; 106():129773. PubMed ID: 38677561
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluation of technetium-99m-labeled propylene amine oxime complexes containing nitroimidazole and nitrotriazole groups as hypoxia markers.
Zhang Q; Huang H; Chu T
J Labelled Comp Radiopharm; 2016 Jan; 59(1):14-23. PubMed ID: 26690916
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Biological Evaluation of a New Nitroimidazole-99mTc-Complex for Imaging of Hypoxia in Mice Model.
Zhang Q; Zhang Q; Guan Y; Liu S; Chen Q; Li X
Med Sci Monit; 2016 Oct; 22():3778-3791. PubMed ID: 27752036
[TBL] [Abstract][Full Text] [Related]
6. Preclinical assessment of hypoxic marker specificity and sensitivity.
Iyer RV; Engelhardt EL; Stobbe CC; Schneider RF; Chapman JD
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):741-5. PubMed ID: 9845088
[TBL] [Abstract][Full Text] [Related]
7. TcO(PnA.O-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase-catalyzed reduction.
Linder KE; Chan YW; Cyr JE; Malley MF; Nowotnik DP; Nunn AD
J Med Chem; 1994 Jan; 37(1):9-17. PubMed ID: 8289205
[TBL] [Abstract][Full Text] [Related]
8. A novel [99mTc[triple bond]N]2+ complex of metronidazole xanthate as a potential agent for targeting hypoxia.
Mallia MB; Mathur A; Subramanian S; Banerjee S; Sarma HD; Venkatesh M
Bioorg Med Chem Lett; 2005 Jul; 15(14):3398-401. PubMed ID: 16044527
[TBL] [Abstract][Full Text] [Related]
9. Scintigraphic imaging of the hypoxia marker (99m)technetium-labeled 2,2'-(1,4-diaminobutane)bis(2-methyl-3-butanone) dioxime (99mTc-labeled HL-91; prognox): noninvasive detection of tumor response to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid.
Siim BG; Laux WT; Rutland MD; Palmer BN; Wilson WR
Cancer Res; 2000 Aug; 60(16):4582-8. PubMed ID: 10969810
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Biological Evaluation of Iodoglucoazomycin (I-GAZ), an Azomycin-Glucose Adduct with Putative Applications in Diagnostic Imaging and Radiotherapy of Hypoxic Tumors.
Kumar P; Elsaidi HR; Zorniak B; Laurens E; Yang J; Bacchu V; Wang M; Wiebe LI
ChemMedChem; 2016 Aug; 11(15):1638-45. PubMed ID: 27377671
[TBL] [Abstract][Full Text] [Related]
11. Radioiodinated azomycin pyranoside (IAZP): a novel non-invasive marker for the assessment of tumor hypoxia.
Mannan RH; Mercer JR; Wiebe LI; Kumar P; Somayaji VV; Chapman JD
J Nucl Biol Med (1991); 1992; 36(1):60-7. PubMed ID: 1450228
[TBL] [Abstract][Full Text] [Related]
12. The synthesis and radiolabeling of 2-nitroimidazole derivatives of cyclam and their preclinical evaluation as positive markers of tumor hypoxia.
Engelhardt EL; Schneider RF; Seeholzer SH; Stobbe CC; Chapman JD
J Nucl Med; 2002 Jun; 43(6):837-50. PubMed ID: 12050331
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo evaluation of [(18)F]F-GAZ, a novel oxygen-mimetic azomycin-glucose conjugate, for imaging hypoxic tumor.
Wuest M; Kumar P; Wang M; Yang J; Jans HS; Wiebe LI
Cancer Biother Radiopharm; 2012 Oct; 27(8):473-80. PubMed ID: 22746267
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro and in vivo characterization of novel 99mTc-'4+1'-labeled 5-nitroimidazole derivatives as potential agents for imaging hypoxia.
Giglio J; Fernández S; Pietzsch HJ; Dematteis S; Moreno M; Pacheco JP; Cerecetto H; Rey A
Nucl Med Biol; 2012 Jul; 39(5):679-86. PubMed ID: 22534030
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution of 99mTc-sunitinib as a potential radiotracer for tumor hypoxia imaging.
Sakr TM; El-Safoury DM; Awad GA; Motaleb MA
J Labelled Comp Radiopharm; 2013 Jun; 56(8):392-5. PubMed ID: 24285479
[TBL] [Abstract][Full Text] [Related]
16. Novel 99mTc aminobisthiolato/monothiolato "3 + 1" mixed ligand complexes: structure-activity relationships and preliminary in vivo validation as brain blood flow imaging agents.
Pirmettis IC; Papadopoulos MS; Chiotellis E
J Med Chem; 1997 Aug; 40(16):2539-46. PubMed ID: 9258360
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of a new 99mTc(I)-tricarbonyl complex bearing the 5-nitroimidazol-1-yl moiety as potential hypoxia imaging agent.
Giglio J; Dematteis S; Fernández S; Cerecetto H; Rey A
J Labelled Comp Radiopharm; 2014 May; 57(6):403-9. PubMed ID: 24692093
[TBL] [Abstract][Full Text] [Related]
18. Technetium(V) oxo complexes of substituted propylene diamine dioxime (PnAO) ligands: water-dependent interconversion between syn and anti isomers.
Cyr JE; Nowotnik DP; Pan Y; Gougoutas JZ; Malley MF; Di Marco J; Nunn AD; Linder KE
Inorg Chem; 2001 Jul; 40(14):3555-61. PubMed ID: 11421705
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of 99mTc(CO)3 complex of 2-methyl-5-nitroimidazole as an agent for targeting tumor hypoxia.
Mallia MB; Subramanian S; Banerjee S; Sarma HD; Venkatesh M
Bioorg Med Chem; 2006 Dec; 14(23):7666-70. PubMed ID: 16949291
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of alkylated derivatives of 99mTc-propylene amine oxime (99mTc-PnAO).
Hoffman TJ; Volkert WA; Corlija M; McKenzie EH; Chaplin SB; Oberle PA; Holmes RA
J Nucl Biol Med (1991); 1992; 36(1):46-51. PubMed ID: 1450225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
